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ABSTRACT  
Coexistence of rheumatoid arthritis and gout is considered as rare  however some patients may gather both diseases. Long-term treatment with 
Methotrexate may cause pulmonary pathology. We report a case  of a 48-year-old Algerian  woman with medical history (swelling of knee  and  
joint pain in the shoulders and hands)  diagnosed with  Rheumatoid  Arthritis  (RA), after  3 years of  self-medication with Methotrexate;  she 
returned with hyperurecimia that   confirmed the co-presence of the gout and RA as well as a pneumonia confirmed with clinical  sign and chest 
X-Ray. Methotrexate dose compliance can reduce adverse effects. 
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INTRODUCTION: 
Rheumatoid  Arthritis  (RA), is an autoimmune  disease,  it is 
known as the  most  frequent  chronic inflammatory  joint 
pathology which is characterized by  excessive synovial  
inflammatory  response  with  osteoarticular  involvements 
01. The gout is an inflammation of the joints or periarticular 
joints triggered by monosodium urate microcrystals (UMC) 
02 involving a defensive reaction of the organism that relies 
primarily on innate immunity 03. Copresent rheumatoid 
arthritis (RA) and gout is very rare.04 
This case report focuses on a 48 Year-Old Algerian woman 
with a history of joint pain at the level of the knees, 
shoulders and hands that were diagnosed as rheumatoid 
arthritis and gout disease. 
CASE REPORT: 
A  48  years  old  Algerian woman in 2015 with a history of  
Diabetes and high blood pressure , was admitted to the 
government hospital for swelling of knee and  joint pain in 
the shoulders and hands since 6 months (The pain  score  
ranging  from 7-8/10). 
She underwent many biological tests that showed a C-
reactive protein (CRP) rate of 24.3 mg/L, a high 
sedimentation rate of 58  mm/h, a positive rheumatoid factor 
(RF) (+++),  An anti-cyclic  citrullinated  peptide  (anti-CCP) 
(+++) and normal uric acid level(4.5 mmol/l) .Our patient 
used Folic acid and methotrexate (MTX). 
One month after this treatment, her symptoms of knee 
swelling and joint pain in the shoulders and hands were 
attenuated however, the patient lost her sight. 
In 2018, the patient came for her usual follow-up; she 
suffered from chest pain, breathing difficulties, dyspnea and 
swelling of knee. 
Due to these symptoms, the patient was subjected to a 
clinical examination, cytobacteriological examination of the 
urine (CEBU), chest X-Ray, C-reactive protein (CRP), 
sedimentation rate, anti-CCP, rheumatoid factor (RF), uric 
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acid, creatinine and blood Glucose. The clinical examination 
shows the presence of nodules in the knees. 
After a week, her exams showed that C-reactive protein 
(CRP) was positive (34.2mg/l) with a high sedimentation 
rate (45 mm/h), positive RF, positive anti-CCP and 
hyperurecimia (10.8mmol/l). 
The CEBU (Cytobacteriological examination of urine) showed 
the presence of sodium urate crystals (Figure 1). 
All her investigations (medicals and biological tests) 
confirmed the coexistence of rheumatoid arthritis and gout 
with each other. 
The chest X-Ray revealed pneumonia (Figure 2). 
MTX treatment was stopped by the doctors, and they decided 
to replace it by colchicines and non steroidal anti-
inflammatory. 
In july 2019, We recorded the patient's death after a 
cerebrovascular accident (stroke). 
 
 
Figure 1: Cytobacteriological examination of urine demonstrating the presence of sodium urate crystals (GR×100) 
 
 
Figure 2: chest X-Ray revealed a pneumonia 
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DISCUSSION: 
The Coexistence of gout and RA is rarely reported. During 
the past 40 years, The English language journals have cited 
the existence of only 24 individual; In Taiwan (Chang Gung 
Memorial Hospital) 08 cases were reported between 1994 
and 2005 04, and  Jebakumar and al found only 22 cases had 
gout prior to the RA incidence in  813 cases05, The incidence 
of gout in RA patients exist but with a low rate 06. Our 
patient with a history of joint pain in the knee, shoulders and 
hands, a normal uric acid level , a positive FR , CRP and Anti-
CCP in the beginning of the diagnosis, what it proves the 
non-existence of gout in the in the beginning, but after 2 
years, this patient returned with swelling of knee and 
hyperurecimia. 
Moreover, Methotrexate (MTX) is a anti-inflammatory and 
immunomodulating, used for the treatment of RA since 
195107, Pulmonary toxicity was reported in 1969 after 
treatment with a high dose MTX 08, the incidence of the 
pulmonary toxicite related MTX  has been reported as low 
(2-8%) 09. Methotrexate may cause more type of pulmonary 
toxicity such as : Inflammatory lung disease, Pulmonary 
infections, Pulmonary malignancy 10 Kremer et al. found that  
patient with rheumatoid arthritis developed  lung injury 
after being treated with methotrexate 11. The woman 
presented in this case report developed pneumonia after 4 
years of treatment with MTX. 
The symptoms of pulmonary disease were: dry cough, 
dyspnea, general discomfort 12. The patient presented in this 
case report had some clinical symptoms of pneumonitis 
(pneumonia) such as breathing difficulties and dyspnea.  
CONCLUSION: 
The Coexistence of gout and RA in the same patient was 
reported to be very rare. It is not frequent but it exists. For 
that reason, levels uric acid should therefore be monitored 
for people with RA  using other techniques for the diagnosis. 
30% of patients treated with Methotrexate for ≥5 years 
develop different pulmonary involvement; that’s why, 
patients need to know how to use methotrexate safely, 
which should be monitored during treatment, and above all, 
avoid self-medication. 
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